Literature DB >> 26336061

Characteristics and outcomes of neutropenia after orthotopic liver transplantation.

Basem Alraddadi1, Natalie E Nierenberg2, Lori Lyn Price3,2,4, Jennifer K L Chow2, Debra D Poutsiaka2, Richard J Rohrer2, Jeffrey T Cooper2, Richard B Freeman5, David R Snydman2.   

Abstract

Neutropenia after orthotopic liver transplantation (LT) is relatively common, but the factors associated with its development remain elusive. We assessed possible predictors of neutropenia (absolute neutrophil count [ANC] ≤ 1000/mm(3) ) within the first year of LT in a cohort of 304 patients at a tertiary medical center between 1999 and 2009 using time-dependent survival analysis to identify risk factors for neutropenia. In addition, we analyzed neutropenia as a predictor of the clinical outcomes of death, bloodstream infection (BSI), invasive fungal infection, cytomegalovirus (CMV) disease, and graft rejection within the first year of LT. Of the 304 LT recipients, 73 (24%) developed neutropenia, 5 (7%) of whom had grade 4 neutropenia (ANC < 500/mm(3) ). The following were independent predictors for neutropenia: Child-Turcotte-Pugh score (hazard ratio [HR] 1.15; 95% confidence interval [CI], 1.03-1.30; P = 0.02), BSI (HR, 2.89; 95% CI, 1.63-5.11; P < 0.001), CMV disease (HR, 4.28; 95% CI, 1.55-11.81; P = 0.005), baseline tacrolimus trough level (HR, 1.02; 95% CI, 1.01-1.03; P = 0.007), and later era LT (2004-2009 versus 1999-2003; HR, 2.28; 95% CI, 1.43-3.65; P < 0.001). Moreover, neutropenia was found to be an independent predictor for mortality within the first year of LT (HR, 3.76; 95% CI, 1.84-7.68; P < 0.001). In conclusion, our data suggest that neutropenia within a year after LT is not unusual and is an important predictor of mortality.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26336061      PMCID: PMC4731308          DOI: 10.1002/lt.24332

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  19 in total

1.  Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.

Authors:  Frank P Hurst; Pallavi Belur; Robert Nee; Lawrence Y Agodoa; Purav Patel; Kevin C Abbott; Rahul M Jindal
Journal:  Transplantation       Date:  2011-07-15       Impact factor: 4.939

2.  Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management.

Authors:  J C Hong; B D Kahan
Journal:  Transplantation       Date:  2000-05-27       Impact factor: 4.939

Review 3.  Definitions of cytomegalovirus infection and disease in transplant recipients.

Authors:  Per Ljungman; Paul Griffiths; Carlos Paya
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

4.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

5.  Improved graft survival after renal transplantation in the United States, 1988 to 1996.

Authors:  S Hariharan; C P Johnson; B A Bresnahan; S E Taranto; M J McIntosh; D Stablein
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

6.  The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients.

Authors:  L Silvia Munoz-Price; Michelle Slifkin; Robin Ruthazer; Debra D Poutsiaka; Susan Hadley; Richard Freeman; Richard Rohrer; Michael Angelis; Jeffrey Cooper; Ralph Fairchild; Laurie Barefoot; Judy Bloom; Susan Fitzmaurice; David R Snydman
Journal:  Clin Infect Dis       Date:  2004-10-11       Impact factor: 9.079

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.

Authors:  Amir A Qamar; Norman D Grace; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Andrew K Burroughs; Cristina Ripoll; Rie Maurer; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Robert Makuch; Gabriel Rendon
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

9.  Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

Authors:  Greg A Knoll; Ian MacDonald; Asmat Khan; Carl Van Walraven
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

10.  Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study.

Authors:  L Zafrani; L Truffaut; H Kreis; D Etienne; C Rafat; S Lechaton; D Anglicheau; J Zuber; M Ciroldi; E Thervet; R Snanoudj; M F Mamzer; F Martinez; M O Timsit; L Bergougnoux; C Legendre
Journal:  Am J Transplant       Date:  2009-06-16       Impact factor: 8.086

View more
  5 in total

1.  Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.

Authors:  Ghady Haidar; Michael Boeckh; Nina Singh
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  Factors associated with neutropenia post heart transplantation.

Authors:  Jennifer K L Chow; Robin Ruthazer; Helen W Boucher; Amanda R Vest; David M DeNofrio; David R Snydman
Journal:  Transpl Infect Dis       Date:  2021-06-01

3.  Safety of Valganciclovir 450 mg 3 Times Weekly for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients Requiring Hemodialysis.

Authors:  Danielle Ecabert; Christine Pham; Brett J Pierce; William L Musick; Duc T Nguyen; Edward A Graviss
Journal:  Open Forum Infect Dis       Date:  2021-08-20       Impact factor: 3.835

4.  Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors.

Authors:  Kavea Panneerselvam; David Szafron; Rajan N Amin; Dongguang Wei; Dongfeng Tan; Mehmet Altan; Pablo C Okhuysen; Malek Shatila; Gottumukkala Subba Raju; Anusha S Thomas; Yinghong Wang
Journal:  Ann Gastroenterol       Date:  2022-07-15

5.  Lung transplant outcomes are influenced by severity of neutropenia and granulocyte colony-stimulating factor treatment.

Authors:  Laneshia Karee Tague; Davide Scozzi; Michael Wallendorf; Brian F Gage; Alexander S Krupnick; Daniel Kreisel; Derek Byers; Ramsey R Hachem; Andrew E Gelman
Journal:  Am J Transplant       Date:  2019-09-26       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.